Cargando…

Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study

BACKGROUND: Viral rebound after nirmatrelvir–ritonavir treatment has implications for the clinical management and isolation of patients with COVID-19. We evaluated an unselected, population-wide cohort to identify the incidence of viral burden rebound and associated risk factors and clinical outcome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Carlos K H, Lau, Kristy T K, Au, Ivan C H, Lau, Eric H Y, Poon, Leo L M, Hung, Ivan F N, Cowling, Benjamin J, Leung, Gabriel M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949892/ https://www.ncbi.nlm.nih.gov/pubmed/36796397 http://dx.doi.org/10.1016/S1473-3099(22)00873-8

Ejemplares similares

Real-world effectiveness of early molnupiravir or nirmatrelvir–ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study
por: Wong, Carlos K H, et al.
Publicado: (2022)

Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study
por: Wong, Carlos K H, et al.
Publicado: (2022)

Estimating excess septicaemia mortality and hospitalisation burden associated with influenza in Hong Kong, 1998 to 2019
por: Wong, Jessica Y., et al.
Publicado: (2022)

Forecasting Influenza Epidemics in Hong Kong
por: Yang, Wan, et al.
Publicado: (2015)

Sepsis-associated hospitalisations and antimicrobial use in Hong Kong
por: Zhang, Weixin, et al.
Publicado: (2021)

Scarlet Fever Outbreak, Hong Kong, 2011
por: Lau, Eric H.Y., et al.
Publicado: (2012)

Electronic School Absenteeism Monitoring and Influenza Surveillance, Hong Kong
por: Cheng, Calvin K.Y., et al.
Publicado: (2012)

Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong
por: Lui, David T. W., et al.
Publicado: (2023)

Epidemiology of Reemerging Scarlet Fever, Hong Kong, 2005–2015
por: Lee, Chun Fan, et al.
Publicado: (2017)

Electronic School Absenteeism System for Multiple Disease Surveillance in Hong Kong
por: Ip, Dennis, et al.
Publicado: (2014)

Mitigation of Influenza B Epidemic with School Closures, Hong Kong, 2018
por: Ali, Sheikh Taslim, et al.
Publicado: (2018)

Dynamic interactions of influenza viruses in Hong Kong during 1998-2018
por: Yang, Wan, et al.
Publicado: (2020)

Effects of School Closures, 2008 Winter Influenza Season, Hong Kong
por: Cowling, Benjamin J., et al.
Publicado: (2008)

Interim estimate of influenza vaccine effectiveness in hospitalised children, Hong Kong, 2017/18
por: Chiu, Susan S, et al.
Publicado: (2018)

Assessing scarlet fever re-emergence from notifiable disease surveillance in Hong Kong
por: Lee, Chun Fan, et al.
Publicado: (2018)

Avian Influenza and Ban on Overnight Poultry Storage in Live Poultry Markets, Hong Kong
por: Leung, Y.H. Connie, et al.
Publicado: (2012)

Genome Sequence of a Human Norovirus GII.4 Hong Kong[P31] Variant in Hong Kong, China
por: Tse, Erin H. Y., et al.
Publicado: (2020)

Restaurant-Based Measures to Control Community Transmission of COVID-19, Hong Kong
por: Ho, Faith, et al.
Publicado: (2022)

Use of DPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVID-19 patients with type 2 diabetes: Propensity score analysis of a territory-wide cohort in Hong Kong
por: Wong, Carlos K.H., et al.
Publicado: (2022)

Thoracic surgery in Hong Kong
por: Chang, Aliss T. C., et al.
Publicado: (2022)

Risk of within-hotel transmission of SARS-CoV-2 during on-arrival quarantine in Hong Kong: an epidemiological and phylogenomic investigation
por: Adam, Dillon C., et al.
Publicado: (2023)

Transmission of Hand, Foot and Mouth Disease and Its Potential Driving Factors in Hong Kong
por: Yang, Bingyi, et al.
Publicado: (2016)

Use of influenza antivirals in patients hospitalized in Hong Kong, 2000-2015
por: Cowling, Benjamin J., et al.
Publicado: (2018)

Burden, seasonal pattern and symptomatology of acute respiratory illnesses with different viral aetiologies in children presenting at outpatient clinics in Hong Kong
por: Wei, L., et al.
Publicado: (2015)

COVID-19 transmission in Hong Kong despite universal masking
por: Martín-Sánchez, Mario, et al.
Publicado: (2021)

The Contribution of Ageing to Hospitalisation Days in Hong Kong: A Decomposition Analysis
por: Kwok, Chi Leung, et al.
Publicado: (2016)

Hospitalizations and mortality during the first year of the COVID-19 pandemic in Hong Kong, China: An observational study
por: Xin, Hualei, et al.
Publicado: (2022)

Prevalence, Incidence, and Sensitization Profile of β-lactam Antibiotic Allergy in Hong Kong
por: Li, Philip H., et al.
Publicado: (2020)

Geriatric hip fracture clinical pathway: the Hong Kong experience
por: Lau, T. W., et al.
Publicado: (2010)

Effects of School-Based Preventive Measures on COVID-19 Incidence, Hong Kong, 2022
por: Tsang, Tim K., et al.
Publicado: (2023)

From a Sprint to a Marathon in Hong Kong
por: Leung, Gabriel M., et al.
Publicado: (2020)

Seasonality of tuberculosis in intermediate endemicity setting dominated by reactivation diseases in Hong Kong
por: Lau, Leonia Hiu Wan, et al.
Publicado: (2021)

Social contact patterns relevant to the spread of respiratory infectious diseases in Hong Kong
por: Leung, Kathy, et al.
Publicado: (2017)

Increases in absenteeism among health care workers in Hong Kong during influenza epidemics, 2004–2009
por: Ip, Dennis K. M., et al.
Publicado: (2015)

Pandemic fatigue impedes mitigation of COVID-19 in Hong Kong
por: Du, Zhanwei, et al.
Publicado: (2022)

A joint analysis of influenza-associated hospitalizations and mortality in Hong Kong, 1998–2013
por: Wu, Peng, et al.
Publicado: (2017)

SARS-related Perceptions in Hong Kong
por: Lau, Joseph T.F., et al.
Publicado: (2005)

A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan
por: Lau, Eric HY, et al.
Publicado: (2010)

School Closure and Mitigation of Pandemic (H1N1) 2009, Hong Kong
por: Wu, Joseph T., et al.
Publicado: (2010)

Ten-year population trends of immunoglobulin use, burden of adult antibody deficiency and feasibility of subcutaneous immunoglobulin (SCIg) replacement in Hong Kong Chinese
por: Kan, Andy Ka Chun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r1g80oph28s7ug3e09m6qhs99g